INNATE, created in 2005 (France), from 2 sister brands and 2214 competing brands. INNATE is owned by Innate Pharma, listed on the stock exchange of Paris The International Securities Identification Number (ISIN) of Innate Pharma is FR0010331421. The sector of INNATE is Biotechnology.

INNATE is a brand of Innate Pharma (IPH) Share price

Share price and profitability of the share Innate Pharma (INNATE)

Buy Innate Pharma share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 2.18

Portfolio valuation
Innate Pharma (INNATE) over 5 years* EUR 0.77

Stock market history Innate Pharma (INNATE)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more